Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Rusch
    Rusch
  3. Wu
    Wu
  4. Travis
    Travis
  5. Kollmeier
    Kollmeier
  6. Kris
    Kris
  7. Riely
    Riely
  8. Alektiar
    Alektiar
  9. Abu-Rustum
    Abu-Rustum
  10. Jakubowski
    Jakubowski

Groups

  1. Department of Medicine (207)
  2. Surgery (145)
  3. Survivorship Research (130)
  4. Solid Tumor Oncology Division (123)
  5. Radiation Oncology, Department of (91)
  6. GSK Faculty (82)
  7. Center for Hematologic Malignancies (80)
  8. Hematologic Malignancies, Division of (73)
  9. Gynecology Disease Management Team (52)
  10. Epidemiology and Biostatistics (51)
Search Within
  1. "2013"
Formats
  1. Journal Article (257)
  2. Meeting Abstract (224)
  3. Book Section (21)
Groups
  1. Department of Medicine (207)
  2. Surgery (145)
  3. Survivorship Research (130)
  4. Solid Tumor Oncology Division (123)
  5. Radiation Oncology, Department of (91)
  6. GSK Faculty (82)

More Groups

People
  1. Sergio Giralt (34)
  2. Abraham Wu (23)
  3. Valerie Rusch (23)
  4. Camelia Sima (20)
  5. Andreas Rimner (19)
  6. Marisa Kollmeier (19)

More People

Years
  1. 2013 (502)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (88)
  2. Journal of Thoracic Oncology (72)
  3. Biology of Blood and Marrow Transplantation (59)
  4. European Journal of Cancer (53)
  5. Gynecologic Oncology (28)
  6. Journal of Sexual Medicine (18)

More Publications

Results (502)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ret fusion-positive advanced lung cancers: Response to first-line chemotherapy and survival in comparison to ROS1 and ALK fusion-positive and EGFR- and KRAS-mutant lung cancers
    Meeting Abstract

    Drilon, A.; Wang, L.; Joubert, P.; Snyder, A.; Cho, E. J.; Riely, G.; Kris, M.; Ladanyi, M.; Rizvi, N.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Histological prognostic markers in squamous cell carcinoma of the lung
    Meeting Abstract

    Drilon, A.; Sima, C. S.; Paik, P. K.; Moreira, A. L.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Evaluation of tolerability and anti-tumor activity of GDC-0980, an oral PI3K/mTOR inhibitor, administered to patients with advanced malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Dolly, S. O.; Krug, L. M.; Wagner, A. J.; Schwartz, L. H.; Bendell, J. C.; Lauchle, J. O.; Seiwert, T. Y.; Rihawi, K.; Tunariu, N.; Zauderer, M. G.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • High local control rates with postoperative radiation therapy in incompletely resected non-small cell lung cancer (NSCLC) patients
    Meeting Abstract

    Din, S. U.; Wu, A. J.; Gelblum, D. Y.; Foster, A.; Chaft, J. E.; Rizk, N. P.; Huang, J.; Rimner, A.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Using generalized equivalent uniform dose (GEUD) to model volume effects for brachial plexopathy after high-dose stereotactic body radiation therapy (SBRT)
    Meeting Abstract

    Din, S. U.; Williams, E. L.; Yamada, Y.; Yorke, E.; Foster, A.; Poppens, E.; Wu, A. J.; Jackson, A.; Rimner, A.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Clinical, structural and biochemical characterization of EGFR exon 20 insertion mutations in lung cancer
    Meeting Abstract

    Costa, D. B.; Yasuda, H.; Park, E.; Yun, C. H.; Huberman, M. S.; Oxnard, G. R.; Sequist, L. V.; Riely, G.; Soo, R.; Eck, M. J.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Clinical experience with crizotinib in patients with advanced ALK-rearranged non-small cell lung cancer and brain metastases in profile 1005 and profile 1007
    Meeting Abstract

    Costa, D. B.; Shaw, A. T.; Ou, S. H. I.; Solomon, B. J.; Riely, G. J.; Ahn, M. J.; Zhou, C. C.; Shreeve, S. M.; Wiltshire, R.; Selaru, P.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Exercise and lung cancer survivorship
    Meeting Abstract

    Corcoran, S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Major pathologic response (<= 10% viable tumor) following neoadjuvant chemotherapy as a surrogate for overall survival in patients with pathologically documented stage IIIA (N2) lung adenocarcinomas
    Meeting Abstract

    Chaft, J. E.; Hellmann, M. D.; Rusch, V. W.; Travis, W. D.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • A phase II study of 18f-FDG PET guided optimization of neoadjuvant chemotherapy for resectable non-small cell lung cancer
    Meeting Abstract

    Chaft, J. E.; Hellmann, M. D.; Dunphy, M.; Jappe, W.; Sima, C. S.; Downey, R. J.; Travis, W. D.; Azzoli, C. G.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save